Activation of physiological cell death mechanisms by a necrosis‐causing agent

Cell death is an important physiological process, but it can be triggered by both physiological and nonphysiological stimuli. The product of the bcl‐2 gene has the ability to inhibit a physiological cell death process that can be activated by a variety of physiological signals, such as growth factor deprivation. This report describes the use of electron microscopy to examine the effects of two cytotoxic drugs on factor‐dependent cells that constitutively express the human bcl‐2 gene. Although all cells treated with sodium azide showed changes typical of necrosis, in the absence of Bcl‐2 the cells died more rapidly and also displayed features of apoptosis. The fact that Bcl‐2 could delay cell death argues that cells can activate internal cell death mechanisms to commit suicide before they are killed by a cytotoxin. Northern analysis showed that growth factor did not preserve viability of the cells through induction of bcl‐2. However, growth factor may prevent activation of the physiological cell death mechanisms that bcl‐2 can control. This process may constitute a primitive defense response, and blocking it may provide a means of limiting damage caused by otherwise sublethal injuries. © 1996 Wiley‐Liss, Inc.

[1]  M. Raff,et al.  Programmed cell death and Bcl‐2 protection in the absence of a nucleus. , 1994, The EMBO journal.

[2]  David L. Vaux,et al.  An evolutionary perspective on apoptosis , 1994, Cell.

[3]  H. Horvitz,et al.  C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2 , 1994, Cell.

[4]  D. Bredesen,et al.  Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. , 1993, Science.

[5]  I. Weissman,et al.  Neither macromolecular synthesis nor myc is required for cell death via the mechanism that can be controlled by Bcl-2 , 1993, Molecular and cellular biology.

[6]  John Calvin Reed,et al.  Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene , 1993, Nature.

[7]  D. Vaux Toward an understanding of the molecular mechanisms of physiological cell death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Warnke,et al.  Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues. , 1993, Blood.

[9]  John Calvin Reed,et al.  Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. , 1993, Blood.

[10]  I. Weissman,et al.  Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. , 1992, Science.

[11]  J. Martinou,et al.  Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. , 1992, Science.

[12]  M. Prevost,et al.  Shigella flexneri induces apoptosis in infected macrophages , 1992, Nature.

[13]  Suzanne Cory,et al.  bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship , 1991, Cell.

[14]  A. Kimchi,et al.  Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 , 1991, Nature.

[15]  T. Cotter,et al.  Disruption of microtubules induces an endogenous suicide pathway in human leukaemia HL‐60 cells , 1990, Cell and tissue kinetics.

[16]  Seamus J. Martin,et al.  Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. , 1990, Journal of immunology.

[17]  T. Dexter,et al.  Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis , 1990, Nature.

[18]  D. Vaux DNA fragmentation in cytolysis. , 1989, Immunology today (Amsterdam. Regular ed.).

[19]  E. Martz,et al.  CTL: virus control cells first and cytolytic cells second? DNA fragmentation, apoptosis and the prelytic halt hypothesis. , 1989, Immunology today.

[20]  David L. Vaux,et al.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.

[21]  D. Spandidos,et al.  Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression. , 1987, British Journal of Cancer.

[22]  M. Negrini,et al.  Molecular analysis of mbcl-2: Structure and expression of the murine gene homologous to the human gene involved in follicular lymphoma , 1987, Cell.

[23]  J. Sklar,et al.  Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation , 1986, Cell.

[24]  A. Duncan,et al.  The frequency and distribution of apoptosis induced by three non-carcinogenic agents in mouse colonic crypts. , 1984, Cancer letters.

[25]  S. Cory,et al.  Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours. , 1983, The EMBO journal.

[26]  J. Ihle,et al.  Constitutive production of a unique lymphokine (IL 3) by the WEHI-3 cell line. , 1982, Journal of immunology.

[27]  E. Scolnick,et al.  Growth of factor-dependent hemopoietic precursor cell lines , 1980, The Journal of experimental medicine.

[28]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[29]  G. Borisy,et al.  THE MECHANISM OF ACTION OF COLCHICINE , 1967, The Journal of cell biology.

[30]  E. Reynolds,et al.  1-Dichloroethylene : An Apoptotic Hepatotoxin ? , 2006 .

[31]  T. Unger,et al.  Expression of the bcl‐2 gene in mouse B lymphocytic cell lines is differentiation stage specific , 1987, European journal of immunology.

[32]  J. Kerr,et al.  Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. , 1982, Pathology annual.